Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

0ELV

Guerbet (0ELV)

Guerbet Sa
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0ELV
FechaHoraFuenteTítuloSímboloCompañía
18/03/202405:37UK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 29 février 2024LSE:0ELVGuerbet Sa
19/02/202410:46UK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2024LSE:0ELVGuerbet Sa
11/12/202310:45PR Newswire (US)Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European UnionLSE:0ELVGuerbet Sa
21/09/202212:08PR Newswire (US)Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)LSE:0ELVGuerbet Sa
13/06/202201:30PR Newswire (US)Guerbet receives EMA acceptance of Elucirem™ as the Brand Name for GadopiclenolLSE:0ELVGuerbet Sa
07/03/202211:00PR Newswire (US)Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolizationLSE:0ELVGuerbet Sa
 Showing the most relevant articles for your search:LSE:0ELV